Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-23-044690
Filing Date
2023-04-12
Accepted
2023-04-12 17:21:12
Documents
1
Period of Report
2023-04-10

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2311755-3_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2311755-3_4seq1.xml 4 7152
  Complete submission text file 0001104659-23-044690.txt   8512
Mailing Address C/O AMPHASTAR PHARMACEUTICALS, INC. 11570 6TH STREET RANCHO CUCAMONGA CA 91730
Business Address
PETERS WILLIAM J (Reporting) CIK: 0001263136 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36509 | Film No.: 23816500

Mailing Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730
Business Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730 909-980-9484
Amphastar Pharmaceuticals, Inc. (Issuer) CIK: 0001297184 (see all company filings)

EIN.: 330702205 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations